Acute Effects of Cannabigerol

Clinical trial NCT05257044 · COMPLETED

Trial details

NCT number: NCT05257044
Sponsor: Washington State University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Focus: To Examine Acute Effects of CBG on Anxiety, Stress, and Cognition

Start date: 2022-03-24
Primary completion: 2023-11-28
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.